 pharmacokinet oral intraven omeprazol patient zollinger-ellison syndrom pharmacokinet pharmacodynam oral IV singl dose patient zollinger-ellison syndrom dose gastric acid hypersecret basi alter pharmacokinet patient singl IV bolu omeprazol mg singl oral dose omeprazol mg intraven oral omeprazol dose week gastric acid secret plasma concentr omeprazol drug administr patient area plasma concentr curv clearanc volum distribut IV omeprazol administr area plasma concentr curv peak plasma concentr time peak oral omeprazol administr differ normal subject patient peptic ulcer diseas mean sem bioavail oral omeprazol patient similar bioavail normal subject patient bioavail normal subject patient bioavail other basal output patient patient invers correl bioavail basal acid output mean sem elimin half-liv IV oral omeprazol differ hour normal subject durat action elimin half-lif drug area plasma concentr curv mean durat action IV oral omeprazol differ hour alter pharmacokinet drug requir omeprazol patient zollinger-ellison syndrom contrast previou studi oral IV omeprazol durat action intermitt bolu administr parenter omeprazol need continu infus histamin antagonist patient parenter antisecretori drug furthermor IV dose hour acid secret patient dose interv patient parenter drug therapi